Internal Medicine

New research finds that the prevalence of opioid use remained high during the study period from 2007 to 2016.

After a high-volume flu season driven by outbreak of the mutated H3N2 strain, Sanofi has bolstered its vaccine class with options specific to older populations.

The second member of the FDA-approved thrombopoietin receptor agonist drug class was proven efficacious and safe in a pair of phase 3 trials.

The 2 assays from Ortho Clinical Diagnosis consolidates the company's package of devices and systems designed to give patients frequent diagnoses.

The long-acting injectable risperidone (Perseris) will provide an alternative to daily oral medication to improve treatment adherence for patients with schizophrenia.

The FDA accepted the NDA for NKTR-181, a drug with slowed entry into the brain that attenuates the dopamine release underlying euphoria.

A vaccine for hepatitis C would likely not eliminate the risk of transmission, but a new study suggests it would dramatically reduce transmission rates among drug users from 90% to 25% or less.

Overweight and obesity in people with HIV are linked to behavioral factors and longer lives, not adverse effects of antiretroviral therapy, according to a new study.

After 18 months of treatment, Study 201 participants at the highest treatment dose demonstrated a statistically significant slowing of cognitive decline of 30% compared to placebo.

Patients in the intensive blood pressure treatment group had a 19% lower risk of developing mild cognitive impairment compared to those given standard treatment, according to the SPRINT MIND study.

A new company says urine tests can help physicians determine whether a patient at risk of HIV infection is adhering to their pre-exposure prophylaxis regimen.

New guidelines on the prevention and treatment of HIV in adults from the IAS-USA Panel highlight advances made since the 2016 guidelines, as well as the need for new strategies.

At the 100-week mark, 89% of participants taking dolutegravir/rilpivirine (Juluca) maintained viral suppression, with viral loads of < 50 copies/mL.

Elagolix (Orlissa) is the first oral gonadotropin-releasing hormone antagonist specifically developed for women with moderate to severe endometriosis pain.

A workgroup convened by the Alzheimer’s Association has developed a list of 20 recommendations regarding symptoms of Alzheimer’s disease and related forms of dementia.

The PocketECG Cardiac Rehabilitation System provides electrocardiography (ECG) monitoring and alerts during cardiac rehabilitation.

A review of literature on depression and anxiety in patients with heart failure reports that 21.5% have depressive symptoms and 19% meet the criteria for a depressive disorder&mdash;2 to 3 times higher than rates in the general population.

One phase 2 study showed that RBX2660, a microbiota-based drug comprised of human stool, was effective in 77.8% of patients.

The cerebrospinal fluid assays can detect biomarkers of Alzheimer disease and help clinicians diagnose AD before clinical symptoms appear.

The ACAAI's new yardstick for pediatric asthma provides guidance on stepping-up asthma treatments to gain and maintain symptom control.

The statistical algorithm incorporates data including age, depression severity, neuroticism, and cognitive control to decide which patients with depression are most likely to benefit from the antidepressant sertraline.

Among men who have sex with men, the increased odds of a new HIV infection per HIV-positive partner was reduced by 91% for each partner with whom condoms were always used.

SYMTUZA has been approved by the FDA based on the data of a pair of 48-week pivotal phase 3 trials which showed the non-inferiority safety and efficacy of the drug versus a controlled regimen.

The paradigm of obesity is complex and requires a multi-disciplinary approach, but it is one of the most gratifying experiences for both the physicians and patient when they see the results of weight loss.

A probiotic hygiene system resulted in a greater reduction of healthcare-associated infections and surface bacteria than chlorine-based cleansers, including a 66.6% reduction of C. difficile.